Expert Review of Clinical Immunology In-vitro assays for immuno-oncology drug efficacy assessment and screening for personalized cancer therapy: scopes and challenges. By , 7 months ago
Expert Review of Clinical Immunology Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma. By , 8 months ago
Expert Review of Clinical Immunology Combination biologics or targeted synthetic disease-modifying anti-rheumatic drugs in the treatment of spondyloarthritis: a systematic literature review. By , 8 months ago
Expert Review of Clinical Immunology What is the relevance of FoxP3 in the tumor microenvironment and cancer outcomes?. By , 8 months ago
Expert Review of Clinical Immunology Preventing fibrosis in IBD: update on immune pathways and clinical strategies. By , 8 months ago
Expert Review of Clinical Immunology Rheumatic adverse events of immune checkpoint inhibitors in cancer immunotherapy. By , 8 months ago
Expert Review of Clinical Immunology Evaluation of ruxolitinib cream 1.5% as an at-home therapy for repigmentation in non-segmental vitiligo. By , 8 months ago
Expert Review of Clinical Immunology Colorectal medullary carcinoma: a pathological subtype with intense immune response and potential to benefit from immune checkpoint inhibitors. By , 8 months ago
Expert Review of Clinical Immunology Antiphospholipid antibodies and the risk of adverse pregnancy outcomes in patients with systemic lupus erythematosus: a systematic review and meta-analysis. By , 8 months ago